HCID 66759906, compound → HCID 86686182, compound

HRID 1409779Notes

Reaction equation

HRID 1409779 reaction equation
[C:1]([C:5]1[N:9]=[C:8]([N:10]2[CH2:15][CH2:14][CH:13]([NH:16][CH:17]3[CH2:19][CH2:18]3)[CH2:12][CH2:11]2)[O:7][N:6]=1)([CH3:4])([CH3:3])[CH3:2].[O:20]1[C:24]([C:25]2[CH:33]=[CH:32][C:28]([C:29](O)=[O:30])=[CH:27][N:26]=2)=[CH:23][N:22]=[CH:21]1>>[C:1]([C:5]1[N:9]=[C:8]([N:10]2[CH2:11][CH2:12][CH:13]([N:16]([CH:17]3[CH2:19][CH2:18]3)[C:29](=[O:30])[C:28]3[CH:32]=[CH:33][C:25]([C:24]4[O:20][CH:21]=[N:22][CH:23]=4)=[N:26][CH:27]=3)[CH2:14][CH2:15]2)[O:7][N:6]=1)([CH3:4])([CH3:2])[CH3:3]

Participants

3

Reactant 2

HCID 66759906HCID 66759906, compoundHCID 68289566[1-(3-Tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine

Product 1

HCID 86686182HCID 86686182, compound

Procedure

The title compound is prepared from [1-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine and 6-oxazol-5-yl-nicotinic acid following a procedure analogous to that described in Example 1. LC (method 7): tR=1.16 min; Mass spectrum (ESI+): m/z=437 [M+H]+.

Sources & evidence

ORD record
ord-513d7f40ddbb45efa3c674cb8a4b3f80
Source dataset
uspto-grants-2014_12
Patent number
US08921398B2

Reaction notes

Loading…